A modeling study of functional magnetic resonance imaging to individualize target definition of seminal vesicles for external beam radiotherapy

Autor: Marianne C. Aznar, J.P. Bangsgaard, Ivan R. Vogelius, Peter Meidahl Petersen, J.B. Thomsen, Sidsel Marie Skov Damkjær, Svetlana I. Petersen
Jazyk: angličtina
Rok vydání: 2017
Předmět:
Organs at Risk
Male
Seminal Vesicles/pathology
medicine.medical_treatment
Prostatic Neoplasms/pathology
Models
Biological

Article
030218 nuclear medicine & medical imaging
Magnetic Resonance Imaging/methods
03 medical and health sciences
Prostate cancer
0302 clinical medicine
Nuclear magnetic resonance
medicine
Humans
Radiology
Nuclear Medicine and imaging

External beam radiotherapy
Organs at Risk/radiation effects
Radiotherapy Planning
Computer-Assisted/methods

medicine.diagnostic_test
Manchester Cancer Research Centre
business.industry
Vesicle
ResearchInstitutes_Networks_Beacons/mcrc
Radiotherapy Planning
Computer-Assisted

food and beverages
Prostatic Neoplasms
Seminal Vesicles
Magnetic resonance imaging
Dose-Response Relationship
Radiation

Radiotherapy Dosage
Hematology
General Medicine
Original Articles
Radiotherapy
Intensity-Modulated/methods

medicine.disease
Magnetic Resonance Imaging
Oncology
030220 oncology & carcinogenesis
Radiotherapy
Intensity-Modulated

Functional magnetic resonance imaging
business
Nuclear medicine
Zdroj: Damkjær, S, Thomsen, J B, Petersen, S I, Bangsgaard, J P, M Petersen, P, Vogelius, I R & Aznar, M C 2017, ' A modeling study of functional magnetic resonance imaging to individualize target definition of seminal vesicles for external beam radiotherapy ', Acta Oncologica, vol. 56, no. 6, pp. 799-805 . https://doi.org/10.1080/0284186X.2017.1300684
Acta Oncologica (Stockholm, Sweden)
Damkjaer, S, Thomsen, J B, Petersen, S I, Bangsgaard, J P, Petersen, P M, Vogelius, I R & Aznar, M C 2017, ' A modeling study of functional magnetic resonance imaging to individualize target definition of seminal vesicles for external beam radiotherapy ', Acta Oncologica, vol. 56, no. 6, pp. 799-805 . https://doi.org/10.1080/0284186X.2017.1300684
DOI: 10.1080/0284186X.2017.1300684
Popis: Background Pre-treatment magnetic resonance imaging (MRI) can give patient-specific evaluation of 25 suspected pathologically-involved volumes in the seminal vesicles (SV) in prostate cancer patients. By 26 targeting this suspicious volume we hypothesize that radiotherapy is more efficient without introducing more 27 toxicity. In this study we evaluate the concept of using MRI-defined target volumes in terms of tumor 28 control probability (TCP) and rectal normal tissue complication probability (NTCP). Materials and methods Twenty-one high-risk prostate cancer patients were included. Pre-treatment CT 30 images, T2 weighted (T2w) MRI and two multi-parametric MRI were acquired. Overlap between a 31 suspicious volume in the SV observed on T2w images and a suspicious volume observed on either multi-32 parametric MRI was assumed to reflect a true malignant region (named “MRI positive”). In addition the 33 entire SV on the CT-scan was delineated. Three treatment plans of 2Gyx39 fractions were generated per 34 patient: one covering the MRI positive volume in SV and prostate with margin of 11 mm to the MRI positive 35 in the SV and two plans covering prostate and SV using 11mm and 7mm SV margin, respectively. All plans 36 prescribed the same PTV mean dose. Rectal NTCP grade≥2 was evaluated with the Lyman-Kutcher-Burman 37 model and TCP was estimated by a logistic model using the combined MRI positive volume in SV and 38 prostate as region-of-interest. Results 14/21 patients were classified as MRI positive, 6 of which had suspicious volumes in all three MRI 40 modalities. On average TCP for the plan covering prostate and the MRI positive volume was 3% higher (up 41 to 11%) than the two other plans which was statistically significant. The increased TCP was obtained without 42 increasing rectal NTCP grade≥2. Conclusion Using functional MRI for individualized target delineation in the seminal vesicles may improve 44 the treatment outcome in radiotherapy of prostate cancer without increasing the rectal toxicity.
Databáze: OpenAIRE